Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Frontiers in Clinical Drug Research -CNS and Neurological Disorders, Volume 4
    Unavailable
    Frontiers in Clinical Drug Research -CNS and Neurological Disorders, Volume 4
    Unavailable
    Frontiers in Clinical Drug Research -CNS and Neurological Disorders, Volume 4
    Ebook674 pages7 hours

    Frontiers in Clinical Drug Research -CNS and Neurological Disorders, Volume 4

    By Vearsa Limited

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Frontiers in Clinical Drug Research - CNS and Neurological Disorders is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.The fourth volume of this series features reviews that cover a variety of topics including:-Multiple sclerosis drug therapy-Treatment of diabetic neuropathy-Migraine treatments-Ischemic stroke treatments-Alzheimer’s disease biomarkers

    LanguageEnglish
    PublisherVearsa Limited
    Release dateMay 31, 2016
    ISBN9781681082950
    Unavailable
    Frontiers in Clinical Drug Research -CNS and Neurological Disorders, Volume 4

    Related to Frontiers in Clinical Drug Research -CNS and Neurological Disorders, Volume 4

    Related ebooks

    Chemistry For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Opinion: A Quantum Of Innovation And The Incentives To Match

      Mar 7, 2019

      Modest tweaks to drugs, what some dismiss as "merely incremental," can represent real and compelling advances for patients and offer great value over time.

      9 min read

    • Article

      Opinion: ‘One-and-done’ For New Drugs Could Cut Patent Thickets And Boost Generic Competition

      Feb 11, 2019

      Instead of patenting new drugs, companies are recycling old ones to build insurmountable patent walls. We can fix that with a "one-and-done" approach that gives each drug one, and only…

      4 min read

    • Article

      Bundles Of Energy

      Jun 4, 2023

      Bundles Of Energy
      9 min read

    • Article

      Dr. William Levine

      Jan 3, 2020

      Dr. William Levine
      5 min read

    • Article

      Opinion: Manufacturing: The Next Breakthrough In Gene Therapy

      Dec 18, 2019

      As the race heats up to bring gene therapy to market, breakthroughs in manufacturing are often the key — or break down the barrier — to delivering these therapies to…

      3 min read

    • Article

      Opinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs

      Jan 30, 2020

      Providing access to antibiotics and other antimicrobials while reducing resistance to these medicines presents a dual manufacturing challenge: ensuring a cost-effective supply while minimizing their emission into the environment.

      4 min read

    • Article

      Could A Drug One Day Block Harmful Stress Responses?

      Jan 29, 2024

      New research could pave the way for new, more specific treatments for stress-​related conditions such as chronic depression with fewer side effects. Stress isn’t merely an oppressive feeling we experience when we’re overwhelmed; it’s the body’s natur

      3 min read

    • Article

      Pill Bottle Perishables

      Aug 13, 2019

      Pill Bottle Perishables
      6 min read

    • Article

      A Game Changer For Cancer?

      Jul 30, 2020

      A Game Changer For Cancer?
      4 min read

    • Article

      Printing Drugs Would Ease Burden of Multiple Pills a Day

      Sep 29, 2017

      A new technology can print pure, precisely customized doses of drugs. The technology could enable on-site printing of custom-dosed medications at pharmacies, hospitals, and other locations. “A doctor or pharmacist can choose any number of medications

      3 min read

    • Article

      New Technologies For Cannabis Production

      Jun 17, 2022

      Researchers are continually seeking new techniques to advance the production of cannabis. In this issue, I’ll discuss three new approaches: Grodan’s e-Gro system, nano-encapsulation and DNA sequencing. Monitoring a large cannabis cultivation facility

      2 min read

    • Article

      Opinion: The FDA Needs To Set Standards For Using Artificial Intelligence In Drug Development

      Nov 7, 2019

      Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet…

      3 min read

    • Article

      Opinion: Substandard Control Arms Question The Utility Of Some New Cancer Drugs

      May 2, 2019

      People being treated for cancer must often withstand physical and financial toxicity. It is only right that new treatments they are offered have been proven to be better than what…

      3 min read

    • Article

      Machine Learning Predicts How Drugs Will Affect Cancer Cells

      Oct 6, 2023

      A new approach can predict how individual cells react to specific treatments, offering hope for more accurate diagnoses and therapeutics. Cancer is triggered by changes in cells that lead to the proliferation of pathogenic tumor cells. In order to fi

      3 min read

    • Article

      The Natural Cancer-fighters

      May 24, 2020

      The Natural Cancer-fighters
      8 min read

    • Article

      Here Come The Right-to-try Profiteers. The FDA Is Powerless To Stop Them

      Jun 20, 2018

      Opinion: The newly enacted right-to-try law allows drug makers to earn a profit by selling unproven therapies to desperate and dying patients. The FDA is powerless to stop it.

      1 min read

    Reviews for Frontiers in Clinical Drug Research -CNS and Neurological Disorders, Volume 4

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words